United Therapeutics market cap UTHR

Share price times shares outstanding: what the whole company sells for, since 2010.

United Therapeutics is worth $25.2B at the close on Oct 23, 2026, at $587.50 a share.

That is up 33% over the last year and up 194% over five years.

Its highest close in our data was $25.8B in Apr 2026.

Market cap over time

Year	End of year	Low	High	Change
2026 so far	$25.2B	$20B	$25.8B	+15%
2025	$21.8B	$12.6B	$22.3B	+36%
2024	$16.1B	$10B	$18.3B	+56%
2023	$10.3B	$9.7B	$12.6B	−18%
2022	$12.7B	$7.6B	$12.8B	+30%
2021	$9.7B	$7.1B	$9.7B	+44%
2020	$6.7B	$3.6B	$6.7B	+73%
2019	$3.9B	$3.3B	$5.5B	−15%
2018	$4.6B	$4.5B	$6.5B	−28%
2017	$6.4B	$5B	$7.1B	+5%
2016	$6.1B	$4.6B	$6.5B	−15%
2015	$7.1B	$5.6B	$8.7B	+14%
2014	$6.3B	$4.2B	$6.4B	+10%
2013	$5.7B	$2.6B	$5.7B	+115%
2012	$2.6B	$2.2B	$3B	−4%
2011	$2.8B	$2.2B	$4B	−23%
2010	$3.6B	$2.7B	$3.6B	n/a

Companies in Biotechnology nearest United Therapeutics' size, closest first, today.

Company	Market cap
UTHRUnited Therapeutics	$25.2B
INCYIncyte	$23.5B
ALNYAlnylam Pharmaceuticals	$30B
EXELExelixis	$16B
ONCBeOne Medicines	$42.9B
NBIXNeurocrine Biosciences	$14.5B
HALOHalozyme Therapeutics	$14.3B
TECHBIO-TECHNE	$11.4B
RGENRepligen	$10B
KRYSKrystal Biotech	$9.2B
REGNRegeneron Pharmaceuticals	$82.9B
Peer median	$15.2B